End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.66 CNY | -1.33% | -7.56% | -38.86% |
05-16 | Olymvax Biopharma's Flu Vaccine Gets China Nod for Clinical Trials | MT |
04-25 | Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-38.86% | 548M | |
+2.22% | 94.37B | |
-0.66% | 38.14B | |
-13.57% | 32.56B | |
+76.24% | 28.24B | |
-12.73% | 15.98B | |
-2.15% | 13.82B | |
-13.59% | 11.57B | |
+158.88% | 10.52B | |
-52.04% | 9.89B |
- Stock Market
- Equities
- 688319 Stock
- News Chengdu Olymvax Biopharmaceuticals Inc.
- Olymvax Biopharma Gets Nod to Amend Packaging of Adsorbed Tetanus Vaccine